English | Español
Patient Daily | Mar 4, 2026

CDC’s principal deputy director Ralph Abraham resigns amid leadership changes
Patient Daily | Mar 4, 2026

Merck restructures human health division ahead of Keytruda patent expiration
Patient Daily | Mar 4, 2026

Vanda receives FDA approval for new antipsychotic after previous setback
Patient Daily | Mar 4, 2026

FDA proposes regulatory path for individualized gene editing therapies targeting rare diseases
Patient Daily | Mar 4, 2026

Congress approves record $315 million for ALS research amid new treatment efforts
Patient Daily | Mar 4, 2026

Appellate court rules for REGENXBIO over Sarepta in gene therapy patent case
Patient Daily | Mar 4, 2026

Novo Nordisk’s obesity drug fails key test against Eli Lilly rival
Patient Daily | Mar 4, 2026

Gilead announces plan to acquire Arcellx for $7.8 billion ahead of FDA decision

Trending
+ Pharmaceuticals
Patient Daily | May 31, 2026

Roswell Park scientists to present five cancer studies at ASCO annual meeting
Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families
+ Regulatory
A. D. Alderman | Jun 3, 2026

New study says TikTok content may normalize illicit vaping among youth as Trump Administration ramps up enforcement
+ Pharmaceuticals
Patient Daily | Jun 1, 2026

Immuneering’s pancreatic cancer drug shows extended survival in Phase 2a trial